Adrian Lee
@Adrianvlee
Followers
2K
Following
7K
Media
285
Statuses
2K
Husband and father, breast cancer researcher and advocate, precision medicine leader, data parasite
Pittsburgh, PA
Joined September 2015
I will no longer be posting on this account. Thanks to all who have followed and engaged. It’s been a privilege to share updates on breast cancer research and precision medicine. Please follow me https://t.co/W45IfPBJvC and/or the IPM https://t.co/M56urlygu7 on LinkedIn
0
0
5
We’re thrilled to have @Adrianvlee (Director, Institute of Precision Medicine, @UPMC) join us at The Festival of Genomics & Biodata in Boston. Adrian will be giving insights into advancing #precisionmedicine in breast cancer. Register now: https://t.co/xRljEjsAOV
#FOGBoston
0
5
13
Interested in Precision Medicine, obesity and/or GLP-1. If so, then listen in to this webinar on Thursday Feb 20th at 3PM EST for a lively discussion on where the field is heading. https://t.co/IGJ7QsYcQn
0
0
7
Day 1 @PMWCintl. Lots of new companies in this space showing a rapidly growing level of innovation. Tomorrow I lead Track 4 on Next Generation Technologies with a focus on ctDNA. @UPMC @PittTweet @UPMCEnterprises
0
2
12
The last 30 days has seen 2746 visitors to the Estrogene website ( https://t.co/ZVUzCadc6j). Please keep spreading this free and user-friendly resource for interrogation and visualization of estrogen and anti-estrogen action in breast cancer #BCSM
0
4
15
Do you use Hallmark_Estrogen_Response_Early/Late signatures from MSigDB? Then try out more comprehensive signatures such as ones we generated from gene expression changes across 66 RNA-seq and 80 microarray experiments e.g. LI_ESTROGENE_META_E2_RESPONSE_UP https://t.co/vKZl8rPndh
1
5
17
Glad to share our latest work on The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer models, now published in @Nature_NPJ #npjBCancer, https://t.co/DSRDgcsTOP, with the super-multifunctional browser
2
6
14
New DepMap Release! ⭐ 35 CRISPR screens ⭐ NEW data from our Pediatric Dependencies Accelerator Program (learn more at https://t.co/Zet00g2IIc) ⭐ First 281 WES -> WGS ⭐ New Resources page 📣 DepMap is now on dbGaP (phs003444.v1.p1) Read our release notes for more info!
1
20
47
Proud of @oesterreichs giving this important lecture and award. Thanks to @AACR and @SABCSSanAntonio
Steffi Oesterreich delivered the AACR Distinguished Lecture in Breast Cancer Research (supported by Aflac, Inc.) today at #SABCS24. She was recognized for her contributions in translational breast cancer research that have advanced our understanding of invasive lobular carcinoma.
5
8
60
1 hr until @oesterreichs presents her AACR Distinguished lecture &@SABCSSanAntonio
Thrilled that Dr. Steffi Oesterreich @oesterreichs is recognized for significant contributions to Breast Cancer Research! Join her for @AACR Distinguished Lecture in Breast Cancer Research! #SABCS24 TODAY | 3:00 pm CT | Stars at Night 1 @UPMCnews @PittHealthSci @UPMCPhysicianEd
1
3
16
Well session was full! Thanks to the panelists and the attendees
0
0
2
1 hour to go to the SABCS educational session on liquid biopsies I will moderate. 👀 room is pretty big..... @SABCSSanAntonio @UPMCHillmanCC @MageeWomens #BCSM
3
0
26
Ready to moderate this afternoon! Come listen in to hear about liquid biopsies - what’s new and what is coming
UPMC Hillman Cancer Center & @PittHealthSci members ready to present @SABCSSanAntonio starting tomorrow. Look for presentations on liquid biopsy, metastatic and lobular cancer, clinical trial data & the latest #CancerResearch on vaccines. #SABCS24 @UPMCnews @UPMCPhysicianEd
0
0
5
Thanks Debbie. This will be an exciting and interactive session. Hoping everyone will come away knowing more about liquid biopsies! @SABCSSanAntonio @UPMCHillmanCC @MageeWomens
@SABCSSanAntonio
#SABCS24 I’m looking forward to this presentation by @Adrianvlee Interesting topic. Tuesday afternoon Don’t miss it!
0
1
9
Happy to collaborate on this important study of regulators of macrophage recruitment in breast cancer. @iPrecisionMed @BCRFcure @SusanGKomen #BCSM
Our paper “Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer” published in OncoImmunology @tandfonline, https://t.co/GVpOTGByav collab. w/ H. Osmanbeyoglu, @oesterreichs and @Adrianvlee, S. Lee & Y. Cho, support by @UPMCHillmanCC @PittBioE
@UPMCnews
0
2
12
1
0
2
Just out our study on immune infiltration in ILC. Proliferative subtype associated with increased suppressive immune infiltration, and signature associated with lower proliferative, pro-inflammatory TAM infiltration, and improved survival in breast cancer. https://t.co/qbVPygN3ck
1
4
21